Renalogic Launches Advisory Board

Renalogic Launches Advisory Board

Jeb Dunkelberger, Richard Jones, Rose Maljanian, and Ryan McDevitt join advisory board for industry leading dialysis cost containment company

PHOENIX, AZ (October 28, 2021) – Renalogic, an industry leader in chronic kidney disease risk management and cost containment, today announced the formation of the company’s Advisory Board. Tasked with helping the company advance its mission to manage the human and financial costs of chronic kidney disease, the Advisory Board includes leading figures from multiple segments of healthcare including employee benefit management, insurance, healthcare providers and academic research.

“When it was founded in 2002, Renalogic was the first company to focus on supporting employers whose employees were affected by chronic kidney diseases,” said Renalogic CEO Kevin Weinstein. “Now, as the company continues to accelerate and break new ground in the fight against kidney disease, we are excited to launch our Advisory Board which will help Renalogic better serve existing and prospective clients, develop new products, and help influence meaningful policy changes.”

Initial members of the Renalogic Advisory Board include (in alphabetical order):

  • Jeb Dunkelberger started his career as a healthcare economist and then transitioned to leading innovation initiatives at McKesson and Highmark. Jeb applied his healthcare expertise for smaller companies before taking over as CEO at Sutter Health | Aetna.
  • Richard Jones has been a strategic advisor to hundreds of clients in the area of employee benefits for the better part of two decades. Earlier in his career, Richard was a management consultant with Accenture, and was part of the staff that produced the 1996 Olympics in Atlanta.
  • Rose Maljanian is currently CEO or HealthCAWS, a privately held health care services company focused on strategic advisory, M&A and platform tools that impact behaviors and outcomes. Earlier in her career Rose held leadership roles with leading provider and payer institutions such as Hartford Hospital, Magellan Health Services, and Humana.
  • Ryan McDevitt is an economics professor associated with both Duke University and the University of Chicago. Ryan is the leading academic doing research into the market dynamics of dialysis.  His work has been featured in numerous economic journals and publications and has been mentioned in leading popular press outlets such as NPR, The Daily Show, and the LA Times.

“With the additional expertise and insights provided by the advisory board, Renalogic is now even better positioned to support our clients and partners,” Weinstein said.

We help brokers and TPAs protect health plan assets everyday. Want to learn more? Contact us today.



Renalogic, headquartered in Phoenix, AZ, was founded in 2002 as a specialty dialysis cost-containment company to help clients understand the unique market dynamics in the dialysis provider community. The company has evolved to become a comprehensive provider of data-driven, end-to-end chronic kidney disease (CKD) care and cost management programs for the self-insured industry. Renalogic’s professional team includes leaders in healthcare administration, care management, legal specialists in ERISA and healthcare law, contract negotiation, payer/provider negotiation, and clinical experts.